|Podcasts|August 19, 2022

Understanding the Patient Journey in Complex and Rare Diseases

Optimizing the use of data and improving the patient experience go hand in hand

Ushank Agarwal, vice president of commercial operations at HUTCHMED, a company developing targeted therapies for cancer and immunological diseases, talks about the importance of monitoring the patient journey in the complex and rare diseases space, and how to get the best out of data in this area.

The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.


Related to this article

CVS Pharmacy Sign at Storefront Entrance | © Mark Roger Bailey - stock.adobe.com 557616813
In this week’s Pharma Pulse, CVS Health plans to separate into two public companies, Bayer weighs what MFN pricing could mean for its launch strategies and an ACTO survey finds most life sciences leaders see no clear industry standard for responsible AI.